logo

BKYI

Bio-key International·NASDAQ
--
--(--)
--
--(--)
9.04 / 10
Outperform

The stock displays strong fundamental strength (9.0/10). Encouraging metrics: Net income-Revenue and Inventory turnover days, whereas limitations surface in Current liabilities / Total liabilities (%) and Non-current liabilities / Total liabilities (%). This profile warrants a excellent stance.

Fundamental(9.04)SentimentTechnical

Analysis Checks(6/10)

Gross profit margin (%)
Value77.30
Score3/3
Weight50.49%
1M Return4.25%
Current liabilities / Total liabilities (%)
Value72.86
Score0/3
Weight-24.14%
1M Return-2.38%
Profit-MV
Value0.62
Score2/3
Weight35.01%
1M Return3.71%
Net income-Revenue
Value-0.05
Score2/3
Weight31.58%
1M Return3.27%
PB-ROE
Value0.98
Score2/3
Weight11.55%
1M Return1.22%
Non-current liabilities / Total liabilities (%)
Value27.14
Score0/3
Weight-25.12%
1M Return-2.46%
Total profit / EBIT (%)
Value102.58
Score1/3
Weight-7.28%
1M Return-0.69%
Asset-MV
Value-0.72
Score1/3
Weight-21.79%
1M Return-2.78%
Inventory turnover days
Value94.66
Score2/3
Weight3.46%
1M Return0.32%
Cash-MV
Value0.01
Score3/3
Weight46.23%
1M Return5.31%
Is BKYI fundamentally strong?
  • BKYI scores 9.04/10 on fundamentals and holds a Discounted valuation at present. Backed by its -58.44% ROE, -67.34% net margin, -1.39 P/E ratio, 0.98 P/B ratio, and 85.27% earnings growth, these metrics solidify its Outperform investment rating.